Product Images Cardioxane

CARDIOXANE® is a medication for intravenous use that comes in a powder form to be dissolved for short infusion. It contains dexrazonane hydrochloride and should be stored in its original container below 25°C, protected from sunlight. The marketing authorization number is PL 3164410002. The text contains additional information and characters that are not readable.*

This is a pharmaceutical product called CARDIOXANE, which comes in a pack of 1 vial and contains 500mg of dexrazoxane. It is a powder for solution used for intravenous infusion. The product should be used within 4 hours after preparation and stored at a temperature between 2°C and 8°C. The package leaflet should be read before use, and any unused product or waste material should be discarded properly. The marketing authorization holder is Clinigen Healthcare Ltd based in the United Kingdom.*

Clinigen Healthcare Ltd. supplies Cardioxane [500mg Powder for Solution for Infusion] with the active ingredient Dexrazoxane for intravenous use in short infusions. The product should be stored in the original container below 25°C and protected from direct sunlight. The Marketing Authorization number is PL 31644/0002. Details about the batch and expiry date are available but not provided in the text.*

Zinecard® is a medication used to help prevent or treat heart damage caused by certain chemotherapy medications. It is given as an injection into a vein before each chemotherapy treatment. Zinecard® helps to protect the heart muscle from the damaging effects of chemotherapy, while still allowing the chemotherapy to kill cancer cells.*

Zinecard* is a medication available in 500 mg dose. Further information is not available due to incomplete and unclear text obtained by .*